Biostage, Inc. announced it raised $900,000 in an initial filing from an offering of $900,000

Company

Location

About

Biostage, Inc. (OTCQB: formerly BSTG) changed its corporate name back to Harvard Apparatus Regenerative Technology, Inc. and began trading under the OTCQB symbol "HRGN" effective July 20, 2023. Harvard Apparatus Regenerative Technology, Inc., is a clinical stage biotechnology company that is focused on the development of organ replacement therapies using cellular scaffolds and tissue engineering to restore organ function.